Eevia Health Plc has received the following notification pursuant to Article 19 of the Market Abuse Regulation:

____________________________________________

Person subject to the notification requirement

Name: Ulve, Stein

Position: Chief Executive Officer

Issuer: Eevia Health Plc

LEI: 743700NO7D0UA8J1MQ31

Notification type: INITIAL NOTIFICATION

Reference number:743700NO7D0UA8J1MQ31_20210622144006_2

____________________________________________

Transaction date: 2021-06-17

Venue: SPOTLIGHT (XSAT)

Instrument type: SHARE

ISIN: FI4000496658

Nature of the transaction: SUBSCRIPTION

Transaction details

(1): Volume: 33,000 Unit price: 0.745 EUR

Aggregated transactions(1): Volume: 33,000 Volume weighted average price: 0.745 EUR

____________________________________________

For more information, please contact: 

Kim Nurmi-Aro, CFO

kim@eeviahealth.com

Tel.: +358 504 44 0717

About Eevia

Eevia Health Plc, founded in March 2017, is a small, but fast-growing Finnish manufacturer of 100% organically certified plant extracts. The Company addresses significant health problems with bioactive compounds extracted from plant material from the pristine Finnish forests near the Arctic Circle. The extracts, which have scientifically documented health benefits, are sold B2B as ingredients to dietary supplements and food brands globally.

To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.